5AM Venture Management, LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001799883

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q2 2026 · 16 positions · Total reported value $287.89M · Top-10 concentration 85.6% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 25.0% · 0 new · 1 cut · 4 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +11.2% · vs SPY -3.6% · Prev Value $360.21M — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2026 13F filing, 5AM Venture Management, LLC disclosed 16 equity positions with a combined reported value of $287.89M. The filing implies a focused portfolio: its ten largest positions account for 85.6% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were MPLT ($34.05M), TYRA ($32.88M), TRDA ($29.85M). By sector, the heaviest allocations are Health Care 94.8%, Industrials 5.2%. Versus the prior quarter, allocation shifted toward Health Care (+4.9pp), Industrials (+1.5pp) and away from Other (-6.4pp).

Versus the prior quarter, 5AM Venture Management, LLC opened 0 new positions, trimmed 1 and fully exited 4, a turnover rate of 25.0% of positions. The portfolio's overlap with the prior quarter was 80% of names.

Of the 4 positions fully exited versus the prior quarter, the largest were ERAS ($56.40M), CNTA ($23.08M), GHRS ($8.05M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

No new positions this quarter.

Fully Exited (vs previous quarter)

  • ERAS ERASCA INC · prev qtr: $56.40M
  • CNTA CENTESSA PHARMACEUTICALS PLC · prev qtr: $23.08M
  • GHRS GH RESEARCH PLC · prev qtr: $8.05M
  • RLYB RALLYBIO CORP · prev qtr: $2.62M

Insider Transactions (Form 4)

Latest 5AM Venture Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

5AM Venture Management, LLC is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q2 2026 it reported 16 US equity positions with a combined value of $287.89M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-120173 (status: Approved), registered 2021-01-19
  • Regulatory AUM (Form ADV): $1.08B as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 12 private funds, of which 1 hedge funds
  • Website: 5amventures.com

Portfolio Structure

  • 16 positions · $287.89M reported value (Q2 2026)
  • Top 10 holdings = 85.6% of reported value
  • Largest position: MPLT (MAPLIGHT THERAPEUTICS INC) at 11.8%
  • Average position size: $17.99M

Sector Tilt

  • Health Care 94.8%
  • Industrials 5.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 1 reduced, 4 exited
  • 15 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The 5AM Venture Management, LLC fund maintained its holdings from the previous quarter, indicating a conservative stance. This suggests a neutral to slightly bullish view on the market, as they did not significantly adjust their positions. 2. Key Moves: - Added/Reduced: The fund did not add or reduce any positions, maintaining all 16 holdings. - By How Much: The percentage weight of each holding remained unchanged, signifying no changes in allocation. 3. Portfolio Structure: - Passive/Active: The fund's rebalancing logic appears to be passive, as it did not make any changes to its portfolio composition. - Sector Bias: The fund has a significant bias towards the healthcare sector, which is reflected in 8 out of 10 top holdings. - Risk Appetite: The fund's conservative approach, maintaining the same positions and not increasing its risk exposure, indicates a low risk appetite. 4. Per-Holding One-Liner: - MPLT (MAPLIGHT THERAPEUTICS INC): Develops therapies for neurological diseases, 'unverified' - TYRA (TYRA BIOSCIENCES INCORPORATED): Focuses on the development of treatments for rare genetic disorders, 'unverified' - TRDA (ENTRADA THERAPEUTICS INC): Engaged in the development of novel treatments for cancer, 'unverified' - PHVS (PHARVARIS N V): Specializes in developing and commercializing therapies for rare and orphan diseases, 'unverified' - CAMP (CAMP4 THERAPEUTICS CORP): Works on the development of treatments for neurological diseases, 'unverified' - ARTV (Latigo Biotherapeutics Inc): Focused on the development of therapies for rare genetic disorders, 'unverified' - TECX (TECTONIC THERAPEUTIC INCORPORA): Involved in the research and development of cancer treatments, 'unverified' - ZNTL (ZENTALIS PHARMACEUTICALS INC): Develops novel treatments for various medical conditions, 'unverified' - CLDX (CELLDEX THERAPEUTICS INC NEW): Engages in the development of cancer therapies, 'unverified' - EYPT (EYEPOINT INC): Focuses on the development of treatments for eye diseases, 'unverified' 5. One-Sentence Style Summary: 5AM Venture Management, LLC maintained its conservative, passive approach to portfolio management this quarter, focusing on a healthcare sector bias with a low risk appetite, while holding onto a steady lineup of healthcare-related investments.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 94.8%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 950.01K $34.05M 11.83%
11.83%
Hold
2 1.03M $32.88M 11.42%
11.42%
Hold
3 4.06M $29.85M 10.37%
10.37%
Hold
4 797.60K $27.58M 9.58%
9.58%
Hold
5 5.87M $25.65M 8.91%
8.91%
Hold
6 2.35M $22.83M 7.93%
7.93%
Hold
7 606.66K $20.85M 7.24%
7.24%
Hold
8 3.95M $19.15M 6.65%
6.65%
Hold
9 497.27K $18.50M 6.43%
6.43%
Hold
10 1.05M $15.02M 5.21%
5.21%
Hold
11 738.97K $11.00M 3.82%
3.82%
Hold
12 271.25K $7.04M 2.44%
2.44%
Reduce
13 9.68M $6.71M 2.33%
2.33%
Hold
14 3.06M $6.33M 2.20%
2.20%
Hold
15 1.37M $5.23M 1.82%
1.82%
Hold
16 476.20K $5.23M 1.82%
1.82%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q2)

P 80% R 80% F1 80% (modelled on 2026-Q1; 8/10 hit)

Low-confidence forecast This fund replaces about 26% of its Top-10 each quarter and backtests at F1 74% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (10 quarters)

Avg precision 74% · recall 74% · F1 74% · avg rank error 2.6 · Top-10 turnover 26%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 70% 70% 70% ELVN · TRDA · PHVS · CLDX · MLTX · BHVN · IRON · DNTH · MRUS · VOR ELVN · TRDA · DNTH · MRUS · CLDX · PRAX · VKTX · PHVS · BHVN · RNAM
2024-Q2 70% 70% 70% ELVN · TRDA · DNTH · MRUS · CLDX · PRAX · PHVS · VKTX · TYRA · RNAM SKYE · TRDA · ELVN · DNTH · CLDX · BHVN · TYRA · PHVS · PRAX · ERAS
2024-Q3 70% 70% 70% SKYE · TRDA · ELVN · DNTH · CLDX · BHVN · TYRA · PHVS · PRAX · ERAS TRDA · ELVN · SKYE · ARTV · DNTH · BHVN · TYRA · CNTA · TECX · PRAX
2024-Q4 70% 70% 70% TRDA · ELVN · SKYE · ARTV · DNTH · BHVN · TYRA · CNTA · TECX · PRAX TRDA · ELVN · SKYE · TECX · ARTV · DNTH · BHVN · PHVS · MLTX · CAMP
2025-Q1 80% 80% 80% TRDA · ELVN · SKYE · TECX · ARTV · DNTH · BHVN · MLTX · PHVS · CAMP TRDA · ELVN · DNTH · SKYE · PHVS · CNTA · CAMP · BHVN · MLTX · VRDN
2025-Q2 80% 80% 80% TRDA · ELVN · DNTH · SKYE · PHVS · CAMP · BHVN · CNTA · MLTX · VRDN SKYE · TRDA · DNTH · ELVN · PHVS · MLTX · CNTA · VOR · VRDN · TECX
2025-Q3 70% 70% 70% SKYE · TRDA · DNTH · ELVN · PHVS · MLTX · CNTA · VRDN · VOR · CLDX SKYE · TRDA · PHVS · CAMP · CNTA · VRDN · ELVN · EYPT · DNTH · TYRA
2025-Q4 70% 70% 70% SKYE · TRDA · PHVS · CAMP · CNTA · VRDN · ELVN · EYPT · DNTH · TYRA TRDA · CAMP · TYRA · VRDN · PHVS · ERAS · EYPT · MPLT · CNTA · CLDX
2026-Q1 80% 80% 80% TRDA · CAMP · TYRA · VRDN · PHVS · ERAS · EYPT · MPLT · CNTA · CLDX ERAS · TRDA · TYRA · CAMP · CNTA · PHVS · MPLT · TECX · CLDX · ARTV
2026-Q2 ★ 80% 80% 80% ERAS · TRDA · TYRA · CAMP · CNTA · PHVS · MPLT · TECX · CLDX · ARTV MPLT · TYRA · TRDA · PHVS · CAMP · ARTV · TECX · ZNTL · CLDX · EYPT

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

FAQ

What did 5AM Venture Management, LLC buy in 2026-Q2?

In its 2026-Q2 13F filing, 5AM Venture Management, LLC reported 16 equity positions worth $287.89M in aggregate; its largest disclosed positions were MPLT ($34.05M), TYRA ($32.88M), TRDA ($29.85M).

How large is 5AM Venture Management, LLC's portfolio?

5AM Venture Management, LLC reported $287.89M of long equity holdings across 16 positions as of 2026-Q2. Top-10 holdings account for 85.6% of reported value.

What is 5AM Venture Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/5am-venture-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →